Raymond James & Associates Increases Stock Position in The Allstate Co. (NYSE:ALL)

Raymond James & Associates increased its position in The Allstate Co. (NYSE:ALL) by 10.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,517,800 shares of the insurance provider’s stock after buying an additional 145,986 shares during the quarter. Raymond James & Associates owned about 0.58% of Allstate worth $287,851,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of ALL. Rise Advisors LLC acquired a new stake in shares of Allstate in the first quarter worth $26,000. Northwest Investment Counselors LLC purchased a new stake in shares of Allstate in the first quarter worth about $26,000. Versant Capital Management Inc grew its stake in shares of Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. purchased a new stake in shares of Allstate during the 2nd quarter valued at about $38,000. Finally, MCF Advisors LLC lifted its position in Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Stock Performance

ALL stock traded down $0.14 during trading on Friday, reaching $195.37. 1,051,563 shares of the company’s stock were exchanged, compared to its average volume of 1,548,418. The firm has a market cap of $51.56 billion, a PE ratio of 43.14, a P/E/G ratio of 1.74 and a beta of 0.48. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.49. The Allstate Co. has a 1-year low of $121.70 and a 1-year high of $198.79. The company’s fifty day moving average price is $186.66 and its 200-day moving average price is $173.80.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The company had revenue of $15.71 billion for the quarter, compared to the consensus estimate of $14.04 billion. During the same period in the previous year, the firm earned ($4.42) EPS. Allstate’s revenue was up 12.4% on a year-over-year basis. On average, research analysts expect that The Allstate Co. will post 15.19 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ALL. The Goldman Sachs Group lifted their price objective on shares of Allstate from $199.00 to $204.00 and gave the company a “buy” rating in a research note on Thursday, August 15th. Raymond James raised their target price on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. Evercore ISI boosted their price target on Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 9th. Piper Sandler raised their price objective on Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a research note on Friday, August 16th. Finally, UBS Group upped their target price on Allstate from $215.00 to $216.00 and gave the company a “buy” rating in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $202.59.

Insider Buying and Selling at Allstate

In related news, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the transaction, the executive vice president now owns 19,163 shares of the company’s stock, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the sale, the executive vice president now owns 19,163 shares of the company’s stock, valued at $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 192,530 shares of company stock valued at $34,967,665. 1.80% of the stock is owned by corporate insiders.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.